Your session is about to expire
← Back to Search
Lifestyle Intervention for Uterine Fibroids
Study Summary
This trial will test a lifestyle program to see if it can help prevent fibroid growth.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I do not speak English.I am not on medications that could affect fibroid growth.I am a woman who has gone through menopause.I had surgery to remove fibroids within the last 3 months and am now considered 'fibroid free.'I am unable to follow a physical activity plan.I can speak, read, and write in English.I am between 18 and 50 years old and seeking care at the NYU Center for Fibroid Care.I had fibroid surgery more than 3 months ago.
- Group 1: Study group
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What is the current participant count of this investigation?
"Affirmative. According to data stored on clinicaltrials.gov, this study is still recruiting suitable participants; the trial was first made available on October 1st 2022 and was recently revised on September 1st 2022. 50 people are needed for enrolment across a single medical centre."
Who is eligible to enroll in this clinical research study?
"To qualify for this research project, candidates must satisfy a range of conditions. Specifically, participants aged 18-50 with leiomyoma who are English speaking and literate, have been ‘fibroid free’ following surgery or treatment within the last 3 months, and visited their physician in that period too; all those attending NYU's Center For Fibroid Care are eligible."
Are there age restrictions on participation in this therapeutic trial?
"This clinical trial is limited to individuals between 18 and 50 years of age. For younger and older patients, there are 1 and 21 trials respectively available for them."
Is recruitment for this trial still ongoing?
"According to the clinicaltrials.gov repository, this trial is still in search for patients and was first posted on October 1st 2022 with an update occurring on September 1st of the same year."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Why did patients apply to this trial?
How responsive is this trial?
Typically responds via
Most responsive sites:
- NYU Langone Health: < 48 hours
Average response time
- < 2 Days
Share this study with friends
Copy Link
Messenger